Lucrose Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 26.43%
- Profit Growth 85.11%
- Ebitda 69.97%
- Net Worth 36.80%
- Total Assets 43.25%
About Lucrose Pharma
Lucrose Pharma Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 July 2016 (Eight years and six months 18 days old ). Its registered office is in Meerut, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anita Singh, Amit Verma, Dinesh Kumar, and One other member serve as directors at the Company.
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999UP2016PTC084888
- Company No.
084888
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Lucrose Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Verma  | Director | 05-Oct-2021 | Current |
| Anita Singh | Director | 08-Aug-2021 | Current |
| Dinesh Kumar | Director | 14-Jul-2016 | Current |
| Gajendra Singh | Director | 14-Jul-2016 | Current |
Financial Performance of Lucrose Pharma.
Lucrose Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.43% increase. The company also saw a substantial improvement in profitability, with a 85.11% increase in profit. The company's net worth Soared by an impressive increase of 36.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lucrose Pharma?
In 2023, Lucrose Pharma had a promoter holding of 82.00% and a public holding of 18.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Diggal Pharma Private LimitedAnita Singh, Amit Verma and 2 more are mutual person
Gda Healthcare Private LimitedAmit Verma, Dinesh Kumar and 1 more are mutual person
- Lucrose Agro Private Limited
Amit Verma, Dinesh Kumar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lucrose Pharma?
Lucrose Pharma has a workforce of 186 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lucrose Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucrose Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
